or
Bookmark and Share
PROCESS FOR THE DETERMINATION OF THYROXINE
   
Document Number
US Patent 3816076
Issued Date
June 11, 1974
Link
Inventors
Map
Abstract
Method for the determination of thyroxine in biological fluids by adsorption on a cation exchanger, subsequent washing out of the interfering components, eluting the adsorbed thyroxine, liberating the iodine therefrom, and then carrying out the iodine determination in a conventional manner, which process is characterized by the use of an eluent, optionally together with a basic buffer, which destroys amino groups and liberates iodine from the thyroxine into the eluate.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
10
Comments:
no comments yet
Published
June 11, 1974
Application Number
05/261,218
Filed
June 9, 1972
US Classification
436/500   436/531 436/825 436/826
Int'l Classification
G01N   33/74   (20060101)   G01N   33/78   (20060101)  
Examiner
Attorney/Law Firm
Priority Data
Jun 15, 1971 [DT] 2129553
USPTO Field of Search
23/23B  
Related Patents
4311690 - Test set and method for the determination of free hormones - Owned by Damon Corporation (Needham Heights, MA)

Disclosed is a process for determining the concentration of unbound hormone, e.g., thyroxine, cortisol, or testosterone, in a liquid sample containing hormone and protein capable of binding the hormone. The sample is incubated with antibody specific to the hormone to be detected and a distinguishable analogue of the hormone, both of which are separated from the sample by semipermeable membranes capable of excluding the passage of natural protein and antibody but which allow passage of the hormone and its analogue. Preferably, the antibody and analogue are contained in semipermeable microcapsules. Free hormone in the sample permeates the membranes and competes for sites of attachment to the antibody with the analogue. The antibody and free hormones are then separated. The amount of analogue present either in association with the antibody or in the remainder of the reaction system is indicative of the level of free hormone originally present in the sample.

4034071 - Immunoassay procedures - Owned by Allegheny General Hospital (Pittsburgh, PA)

The technique of separating a tagged bound material from the same unbound material in immunoassay procedures is improved by utilizing a clathrate sorbent to carry out the separation. A clathrate sorbent, for example, comprises a mixture of hydrate zinc sulfate and sodium hydroxide which form an inclusion compound with charcoal powder. Charcoal powder has also been combined to form a clathrate sorbent with salts of other metals which produce a gelatinous substance with alkaline hydroxides; e.g., alum with sodium hydroxide. Another example of a clathrate sorbent is magnesium trisilicate combined with the aforementioned zinc preparation.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us